Get Your Personalized Supplement StackSupplement Stack Quiz

Red Peony

Also known as: Red Peony, Chinese Peony, Shao Yao, Total glucosides of peony, TGP, Paeonia lactiflora

Overview

Red Peony refers to extracts derived from the root of Paeonia lactiflora, a plant widely utilized in Traditional Chinese Medicine (TCM) for its anti-inflammatory and immunomodulatory properties. The primary bioactive compounds are total glucosides of peony (TGP), with paeoniflorin being the most significant. It is commonly applied in the management of autoimmune and inflammatory conditions such as rheumatoid arthritis and psoriasis, and also recognized for its analgesic effects. Research on Red Peony is moderately mature, with several randomized controlled trials (RCTs) and systematic reviews supporting its clinical use, particularly as an adjunct to conventional therapies. The evidence quality varies but includes well-conducted meta-analyses and RCTs, indicating its potential as a complementary treatment.

Benefits

Red Peony offers several evidence-based benefits, primarily due to its anti-inflammatory, antioxidant, and immunomodulatory effects. For rheumatoid arthritis (RA), a 2017 systematic review and meta-analysis of RCTs demonstrated that TGP, when combined with methotrexate, significantly improved clinical symptoms and inflammatory markers compared to methotrexate alone, with a favorable safety profile. This suggests its efficacy as an adjunctive therapy for RA patients. In psoriasis, a 2024 systematic review and meta-analysis of 43 studies involving 4150 subjects found that TCM formulations containing red peony components improved psoriasis symptoms versus controls, showing statistically significant effect sizes and acceptable safety. Furthermore, paeoniflorin, the main active ingredient, has exhibited significant analgesic effects in preclinical and clinical studies by reducing inflammatory cytokines (IL-1β, TNF-α), oxidative stress, and modulating pain signaling pathways (MAPK, TRPV1). This supports its potential use for chronic inflammatory and neuropathic pain management.

How it works

Red Peony exerts its therapeutic effects through multiple mechanisms. Its anti-inflammatory action involves inhibiting pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α, and suppressing NF-κB signaling in macrophages, thereby reducing immune activation. As an antioxidant, it limits reactive oxygen species (ROS) levels, protecting tissues from oxidative damage. For pain modulation, paeoniflorin regulates pain-related pathways including MAPK and TRPV1, contributing to its analgesic effects. Additionally, it demonstrates immunomodulatory properties by affecting NLRP inflammasomes and TLR signaling, helping to balance immune activity in autoimmune conditions. While paeoniflorin is water-soluble, its bioavailability is moderate, and formulations often aim to enhance absorption.

Side effects

Red Peony extracts and TGP are generally considered safe, with a low incidence of adverse effects reported in clinical trials. The most common side effects, occurring in more than 5% of users, are mild gastrointestinal symptoms such as nausea or diarrhea, though these are generally infrequent. Uncommon side effects, affecting 1-5% of users, include rare occurrences of allergic reactions or skin rash. Serious adverse events have not been consistently reported in high-quality randomized controlled trials, with rare side effects occurring in less than 1% of users. Regarding drug interactions, potential interactions with immunosuppressants like methotrexate exist, but clinical studies have shown that combination therapy with TGP and methotrexate does not raise significant safety concerns, requiring monitoring. Contraindications are not extensively documented; however, caution is advised during pregnancy and lactation due to a lack of sufficient safety data in these populations. Data on the use of Red Peony in children and the elderly are limited, as most studies have focused on adult patients with autoimmune diseases.

Dosage

Effective doses of Red Peony vary by formulation and indication. Clinical trials involving Total Glucosides of Peony (TGP) typically use a dosage range of 600-1200 mg per day of standardized extract, often administered in combination with conventional drugs. Optimal dosing is dependent on the specific indication and whether it is used as part of a combination therapy, as data on monotherapy are limited. While a maximum safe dose has not been definitively established, doses up to 1200 mg/day have demonstrated good tolerability in clinical trials. Red Peony is usually administered orally in divided doses, often with meals, to potentially improve absorption and minimize gastrointestinal side effects. For reproducibility and consistent efficacy, standardized extracts with quantified paeoniflorin content are preferred. Co-administration with food may enhance bioavailability, and no specific cofactors are required for its absorption.

FAQs

Is red peony effective alone or only combined with other drugs?

Evidence primarily supports Red Peony's benefit as an adjunct to conventional therapies, such as methotrexate for rheumatoid arthritis, rather than as a standalone treatment.

How soon do benefits appear?

Clinical improvements, particularly in conditions like rheumatoid arthritis, are typically observed within weeks to a few months of consistent treatment with Red Peony.

Is it safe long-term?

While short-to-medium term use of Red Peony appears safe based on current research, long-term safety data are still limited.

Can it replace conventional drugs?

Current evidence does not support Red Peony as a replacement for conventional drugs; rather, it is recommended for adjunctive use to complement existing treatments.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC5754451/ – This systematic review and meta-analysis by Feng et al. (2017) found that Total Glucosides of Peony (TGP) combined with methotrexate significantly improved symptoms and inflammatory markers in rheumatoid arthritis patients compared to methotrexate alone. The study indicated a favorable safety profile for the combination therapy, despite some heterogeneity among included trials.
https://www.longdom.org/open-access/systematic-review-and-metaanalysis-of-the-curative-effect-of-traditional-chinese-medicine-on-psoriasis-under-105667.html – A 2024 systematic review and meta-analysis, including 43 studies and 4150 subjects, demonstrated that Traditional Chinese Medicine formulations containing red peony components significantly improved psoriasis symptoms. The study, utilizing Cochrane methodology, supported the clinical efficacy and acceptable safety of these formulations for psoriasis.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11365469/ – This focused review by Li et al. (2024) summarized preclinical and clinical studies on paeoniflorin's analgesic effects. It highlighted mechanisms such as inhibition of inflammatory cytokines and modulation of pain signaling pathways, supporting paeoniflorin's potential as a non-opioid analgesic agent, though it noted the need for more large-scale RCTs.

Score: 68/100

Osteoherbal

Health Concerns

Score: 78/100